Hundreds of prescription medications process every day and patients and plan sponsors pay for them because that's what...
Read MoreNonalcoholic steatohepatitis (NASH) is a type of nonalcoholic fatty liver disease (NAFLD). Like its name states, NASH...
Read MoreSpring has sprung and so have the announcements from Centers for Medicare and Medicaid Services (CMS). The month of...
Read MoreWhen the pandemic hit, people learned new ways to work, shop and communicate. They also switched to mail order pharmacy...
Read MoreThe Inflation Reduction Act (IRA) was signed into law in August 2022 and went into effect January 1, 2023. The IRA...
Read MoreWhile specialty medications provide a new level of hope for people being treated for serious conditions such as...
Read MoreFrom biosimilars and COVID-19 to gene therapy and microbiomes, there are several developments in the pipeline to watch...
Read MoreThe 2022 audit cycle is coming to a close. CMS issued its last engagement letters for 2022 program audits at the end of...
Read MoreDiabetes is an epidemic that drives a significant amount of medical cost. Eleven percent of the United States’...
Read MoreAt Elixir, whole member health is at the heart of our formulary strategy and drug management practices. As we prepare...
Read More